Zhengqun Luo
Overview
Explore the profile of Zhengqun Luo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
3
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Su X, Liu Y, Zhong Y, Shangguan P, Liu J, Luo Z, et al.
Nano Lett
. 2025 Feb;
25(9):3445-3454.
PMID: 39992704
Glioblastoma is the most common and devastating brain tumor owing to its high invasiveness and high-frequency drug resistance. Near infrared-II (NIR-II) imaging-guided phototherapy based on polymer luminogens provides a promising...
2.
Wang J, Cao M, Han L, Shangguan P, Liu Y, Zhong Y, et al.
J Am Chem Soc
. 2024 Oct;
146(42):28783-28794.
PMID: 39394087
Currently used drugs for glioblastoma (GBM) treatments are ineffective, primarily due to the significant challenges posed by strong drug resistance, poor blood-brain barrier (BBB) permeability, and the lack of tumor...
3.
Liu Y, Lv X, Zhong Y, Wang G, Liu S, Chen S, et al.
Molecules
. 2024 Aug;
29(16).
PMID: 39202950
Photoactive artificial nanocatalysts that mimic natural photoenergy systems can yield clean and renewable energy. However, their poor photoabsorption capability and disfavored photogenic electron-hole recombination hinder their production. Herein, we designed...
4.
Wang J, Shangguan P, Lin M, Fu L, Liu Y, Han L, et al.
ACS Nano
. 2023 Aug;
17(17):16840-16853.
PMID: 37605553
Glioblastoma multiforme (GBM) is the most common malignant brain tumor with low survival, primarily due to the blood-brain barrier (BBB) and high infiltration. Upconversion nanoparticles (UCNPs)-based near-infrared (NIR) phototherapy with...